Skye Bioscience Inc (SKYE)

[frozenspokes]

MRSA Indication:

http://newswise.com/articles/new-mrsa-defense-new-study-reports-cannabinoid-effective-against-antibiotic-resistant-mrsa

NMUS operates like a seasoned biotech. They publish news that is relevant and when it is valuable to disclose milestones to the biotech and investment community. This MRSA solution is worth more than the combination of 90% of the companies that are part of that ETF.

No fluff, never has been and never will be with NMUS. Their management team is all biotech guys. They don't mess around with B.S. fluff PR's...just real info - a real biotech that operates that way. When they close on this next round of funding I expect they will announce the funds will be used to start the human trials. When that happens, there will be no looking back.